1. Current management of hemophilia B: recommendations, complications and emerging issues
2. World Federation of Hemophilia. Report on the annual global survey 2021; 2022; Available from: https://www1.wfh.org/publications/files/pdf-2324.pdf. Accessed November 20, 2023.
3. Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates
4. Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B
5. Pharmaceuticals and Medical Devices Agency. Refixia (nonacog beta pegol) Japanese regulatory review: report on the deliberation results; 2018; Available from: https://www.pmda.go.jp/files/000238159.pdf. Accessed February 8, 2023.